NICE recommends degarelix for men with advanced hormone-dependent prostate cancer and spinal metastases

The National Institute for Health and Care Excellence (NICE) has recommended degarelix (marketed as 'Firmagon') for a group of men with advanced hormone-dependent prostate cancer – those with spinal metastases. This announcement comes after a review...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/297TMvn
via IFTTT